Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Qu Biologics Appoints Clinical Ops VP | Contract Pharma

What are you searching for?

Sign in
Breaking News

Qu Biologics Appoints Clinical Ops VP

Gluck to lead clinical trial programs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Rashieda Gluck has been appointed vice president of Clinical Operations at Qu Biologics, Inc. Ms. Gluck will lead development, execution, and delivery of the company’s clinical trial programs. Qu Biologics develops Site Specific Immunomodulators (SSIs) that aim to ‘reboot’ the body’s immune system to treat cancer and autoimmune disease.
 
Qu Biologics’ chief executive officer, Dr. Hal Gunn, said, “We are at an important stage of our growth with one clinical trial in Crohn’s disease ongoing and other trials in cancer being planned. Rashieda’s more than 20 years of clinical operations experience will be valuable to the development of our clinical programs as we further investigate the potential treatment benefits of our site specific immunomodulators. We are very pleased to welcome her to the leadership team.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters